Your browser doesn't support javascript.
loading
Interferons limit autoantigen-specific CD8+ T-cell expansion in the non-obese diabetic mouse.
Jhala, Gaurang; Krishnamurthy, Balasubramanian; Brodnicki, Thomas C; Ge, Tingting; Akazawa, Satoru; Selck, Claudia; Trivedi, Prerak M; Pappas, Evan G; Mackin, Leanne; Principe, Nicola; Brémaud, Erwan; De George, David J; Boon, Louis; Smyth, Ian; Chee, Jonathan; Kay, Thomas W H; Thomas, Helen E.
Afiliação
  • Jhala G; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia.
  • Krishnamurthy B; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC 3065, Australia.
  • Brodnicki TC; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC 3065, Australia; Department of Microbiology and Immunology, University of Melbourne, Parkville, VIC 3010, Australia.
  • Ge T; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC 3065, Australia.
  • Akazawa S; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia.
  • Selck C; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia.
  • Trivedi PM; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia.
  • Pappas EG; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia.
  • Mackin L; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia.
  • Principe N; National Centre of Asbestos-Related Diseases, Institute of Respiratory Health, School of Biomedical Science, University of Western Australia, Nedlands, WA 6009, Australia.
  • Brémaud E; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia.
  • De George DJ; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC 3065, Australia.
  • Boon L; Polpharma Biologics, 3584 CM Utrecht, the Netherlands.
  • Smyth I; Australian Phenomics Network, Monash Genome Modification Platform, Monash University, Clayton, VIC 3800, Australia; Development and Stem Cells Program, Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Clayton, VIC 3800, Australia.
  • Chee J; National Centre of Asbestos-Related Diseases, Institute of Respiratory Health, School of Biomedical Science, University of Western Australia, Nedlands, WA 6009, Australia.
  • Kay TWH; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC 3065, Australia. Electronic address: tkay@svi.edu.au.
  • Thomas HE; Immunology and Diabetes Unit, St Vincent's Institute, Fitzroy, VIC 3065, Australia; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC 3065, Australia.
Cell Rep ; 39(4): 110747, 2022 04 26.
Article em En | MEDLINE | ID: mdl-35476975
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-2 / Diabetes Mellitus Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-2 / Diabetes Mellitus Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article